Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
AdAlta Ltd. ( (AU:1AD) ) just unveiled an announcement.
AdAlta Ltd. has announced the quotation of 41,666,667 new fully paid ordinary securities on the Australian Securities Exchange (ASX) under the code 1AD. This move is part of previously announced transactions and is expected to enhance the company’s financial flexibility, potentially impacting its market position and providing opportunities for growth and development.
More about AdAlta Ltd.
AdAlta Ltd. operates in the biotechnology industry, focusing on the development of novel therapeutic products. The company is known for its proprietary i-body technology, which is used to create new treatments for diseases with unmet medical needs.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$2.68M
For an in-depth examination of 1AD stock, go to TipRanks’ Overview page.